BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15592708)

  • 1. [Retroperitoneal lymph node dissection in testis cancer].
    Pottek T;
    Urologe A; 2004 Dec; 43(12):1514-20. PubMed ID: 15592708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retroperitoneal lymph node dissection for patients with advanced testicular tumor].
    Takasaki N; Ueda H; Isurugi K
    Hinyokika Kiyo; 1994 Oct; 40(10):957-61. PubMed ID: 7992714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumors.
    Herr HW; Toner GC; Geller NL; Bosl GJ
    Eur Urol; 1991; 19(1):1-5. PubMed ID: 1848821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reoperative retroperitoneal lymph node dissection for metastatic germ cell tumors: analysis of local recurrence and predictors of survival.
    Pedrosa JA; Masterson TA; Rice KR; Bihrle R; Beck SD; Foster RS
    J Urol; 2014 Jun; 191(6):1777-82. PubMed ID: 24518787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Fornara P; Hoda MR
    Eur Urol; 2008 Nov; 54(5):1015-6. PubMed ID: 18722706
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Pizzocaro G
    Eur Urol; 2008 Nov; 54(5):1017-8. PubMed ID: 18722705
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Albers P
    Eur Urol; 2008 Nov; 54(5):1016-7. PubMed ID: 18722703
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Mottet N
    Eur Urol; 2008 Nov; 54(5):1018-9. PubMed ID: 18722702
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].
    Heidenreich A; Krege S; Flasshove M
    Urologe A; 2004 Dec; 43(12):1521-30. PubMed ID: 15592709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.
    Garnick MB
    J Clin Oncol; 2007 Oct; 25(28):4337-8. PubMed ID: 17906195
    [No Abstract]   [Full Text] [Related]  

  • 18. Reoperative retroperitoneal lymph-node dissection for testicular germ cell tumor.
    Murphy AM; McKiernan JM
    World J Urol; 2009 Aug; 27(4):501-6. PubMed ID: 19636565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphadenectomy for testicular cancer. Diagnostic and prognostic significance as well as therapeutic benefit].
    Krege S; Rübben H
    Urologe A; 2005 Jun; 44(6):652-6. PubMed ID: 15905990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.